Federal Judge Tosses The First AndroGel Bellwether Verdict
Federal Judge Tosses The First AndroGel Bellwether Verdict
Introduction
The first AndroGel bellwether trial announced in favor of the plaintiff awarding him $150 million as punitive damages and no compensatory damages in June 2017 was tossed by the U.S. District Judge Matthew F. Kennelly, overseeing 6,000 plus testosterone replacement lawsuits centralized under MDL 2545 (In re: Testosterone Replacement Therapy Products Liability Litigation). The $150 million verdict was announced to punish AbbVie for its conduct in spite of acknowledging that the plaintiff’s heart attack was not caused by AbbVie’s product in question. This decision was based on the fact that the federal judge found the jury conclusions “logically incompatible.’’ He further ordered a new trial for this case to be convened on March 5, with a pretrial status conference scheduled for February 28th.
Comments
Latest News
Study Links Roundup Chemical to Long-Term Brain Damage
Categories: Roundup
A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Categories: Zimmer Hip/Knee Replacement
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
Categories: Hernia Mesh
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…